News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Muller Lorenz
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2022 |
4
| Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 160,000 options to buy
@ $5.46, valued at
$873.6k
|
|
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2020 |
4
| Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Exercised 5,700 options to buy
@ $1.54, valued at
$8.8k
|
|
| 06/08/2020 |
4
| Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Exercised 2,500 options to buy
@ $1.54, valued at
$3.9k
Exercised 32,528 options to buy
@ $1.54, valued at
$50.1k
Exercised 18,043 options to buy
@ $1.54, valued at
$27.8k
Granted 35,000 options to buy
@ $3.74, valued at
$130.9k
|
|
| 01/24/2020 |
4
| Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 60,000 options to buy
@ $21.48, valued at
$1.3M
|
|
| 05/08/2019 |
3
| Muller Lorenz (Chief Commercial Officer) has filed a Form 3 on Milestone Pharmaceuticals Inc. |
|
|